Skip to main content
. 2022 Jul 27;276(5):761–768. doi: 10.1097/SLA.0000000000005632

TABLE 1.

Baseline Characteristics (N=104)

Value
Variables Intervention Group (n=50) n (%) Control Group (n=54) n (%)
Age [mean (SD)/median (IQR)] (y) 58.8 (12.7) 57.1 (10.9)
 ≤49 11 (22.0) 14 (25.9)
 50–69 29 (58.0) 35 (64.8)
 ≥70 10 (20.0) 5 (9.3)
Sex
 Male 36 (72.0) 35 (64.8)
 Female 14 (28.0) 19 (35.2)
BMI [mean (SD)/median (IQR)] (kg/m2) 24.6 (4.0) 24.1 (3.7)
 <25.0 28 (56.0) 30 (55.6)
 25.1–30.0 19 (38.0) 16 (29.6)
 >30.0 3 (6.0) 8 (14.8)
Partner
 Yes 46 (92.0) 48 (88.9)
 No 4 (8.0) 6 (11.1)
Employment status
 Retired 23 (46.0) 17 (31.5)
 Employed/unemployed 27 (54.0) 27 (68.5)
Tumor height*
 Low (0–5 cm) 29 (58.0) 31 (59.3)
 Mid (5.1–10 cm) 14 (28.0) 16 (29.6)
 High (10.1–15 cm) 7 (14.0) 7 (11.1)
Type of reconstruction
 Straight coloanal anastomosis 36 (72.0) 31 (57.4)
 Side-to-end coloanal anastomosis 5 (10.0) 16 (29.6)
 Colon pouch-anal anastomosis/J-pouch 9 (18.0) 7 (13.0)
Anastomosis
 Handsewn 15 (30.0) 17 (31.5)
 Stapled 35 (70.0) 37 (68.5)
Neoadjuvant therapy
 No 15 (30.0) 16 (29.6)
 Chemotherapy and/or radiotherapy 35 (70.0) 38 (70.4)
Adjuvant therapy
 No 26 (52.0) 28 (51.9)
 Chemotherapy 23 (46.0) 25 (46.2)
 Chemoradiotherapy 1 (2.0) 1 (1.9)
Stoma
 Yes 43 (86.0) 47 (87.0)
 No 7 (14.0) 7 (13.0)
*

From the anal verge.

BMI indicates body mass index; IQR, interquartile range.